News

Filter

Current filters:

ResearchRoche

1 to 9 of 172 results

Roche announces positive Phase III results of Gazyva in non-Hodgkin's lymphoma

Roche announces positive Phase III results of Gazyva in non-Hodgkin's lymphoma

04-02-2015

Swiss drug major Roche has announced positive results from the Phase III study of Gazyva (obintuzumab)…

GazyvaOncologyPharmaceuticalResearchRoche

Chugai to expand Singapore R&D unit with $476 million investment

03-02-2015

Japan's Chugai Pharmaceutical, which is majority owned by Swiss pharma giant Roche, plans to invest $476…

Chugai PharmaceuticalFinancialPharmaceuticalResearchRocheSingapore

Roche, Meiji and Fedora team up to commercialize antibiotic OP0595

Roche, Meiji and Fedora team up to commercialize antibiotic OP0595

13-01-2015

Swiss pharma major Roche, Japanese pharma company Meiji Seika and private biotech company Fedora have…

Antibiotics and Infectious diseasesMeiji Seika PharmaOP0595PharmaceuticalResearchRoche

23andMe and Genentech in deal to analyze genomic data for Parkinson's disease

06-01-2015

23andMe, the leading personal genetics company, and Genentech, a subsidiary of Swiss pharma giant Roche,…

23andMeBiotechnologyGenentechNeurologicalResearchRoche

Roche ends Phase III trial of gantenerumab in prodromal Alzheimer’s disease

Roche ends Phase III trial of gantenerumab in prodromal Alzheimer’s disease

22-12-2014

Swiss drug major Roche is to end the Phase III study of experimental anti-amyloid drug gantenerumab in…

gantenerumabNeurologicalPharmaceuticalResearchRocheSwitzerland

Phylogica inks $142 million license deal with Genentech

Phylogica inks $142 million license deal with Genentech

22-12-2014

Australian drug discovery firm Phylogica has extended its collaboration with Genentech, the biotech subsidiary…

Antibiotics and Infectious diseasesAustraliaBiotechnologyGenentechLicensingPhylogicaResearchRoche

Global oncology market to hit $109 billion in 2020

Global oncology market to hit $109 billion in 2020

26-11-2014

Cancer, with a death toll exceeding that of AIDS (acquired immune deficiency syndrome), tuberculosis…

AvastinCelgene Corp.GlobalMarkets & MarketingMergers & AcquisitionsNovartisOncologyPharmaceuticalResearchRevlimidRoche

1 to 9 of 172 results

COMPANY SPOTLIGHT

Menarini

Back to top